Highly selective SYK inhibitor, GSK143, abrogates survival signals in chronic lymphocytic leukaemia.

Varghese, Abraham M

Highly selective SYK inhibitor, GSK143, abrogates survival signals in chronic lymphocytic leukaemia. [electronic resource] - British journal of haematology 09 2018 - 927-930 p. digital

Publication Type: Letter

1365-2141

10.1111/bjh.14884 doi


Aniline Compounds--pharmacology
Calcium Signaling--drug effects
Cell Survival--drug effects
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Phosphorylation--drug effects
Pyrimidines--pharmacology
Syk Kinase--antagonists & inhibitors
Tumor Cells, Cultured